EUVIMEDEUVIMED entdecken
Crossref

L’EBV e il paradosso dell’infezione precoce: protezione o rischio?

Alberto Tommasini

Medico e Bambino · 15.04.2026 · 45 (4) · 225-230

DOI: 10.53126/meb45225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medico e Bambino, erschienen am 15.04.2026. Verfasst von Alberto Tommasini. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Epstein-Barr virus (EBV) is one of the most fascinating paradoxes of modern medicine: a nearly ubiquitous pathogen that in most cases causes benign infections, but it may be lethal in individuals with specific genetic vulnerabilities and, in a fraction of apparently healthy subjects, may trigger devastating autoimmune diseases many years later. In recent years, epidemiological studies of extraordinary scope and mechanistic research of great elegance have revolutionised the understanding of how, when and why EBV becomes pathogenic. The article reviews the classical knowledge about infectious mononucleosis and integrates it with the most recent discoveries, which tell a story of timing, genetics and immunological misfortune that culminates in an apparently paradoxical provocation: in the absence of vaccines, might it be better for children to encounter this virus when they are ‘young’ rather than when they are ‘older’?

Zitieren

APA

Tommasini, A. (2026). L’EBV e il paradosso dell’infezione precoce: protezione o rischio?. Medico e Bambino, 45(4), 225-230. https://doi.org/10.53126/meb45225

Vancouver

Tommasini A. L’EBV e il paradosso dell’infezione precoce: protezione o rischio?. Medico e Bambino. 2026;45(4):225-230. doi:10.53126/meb45225

BibTeX
@article{Tommasini2026,
  author = {Tommasini, Alberto},
  title = {L’EBV e il paradosso dell’infezione precoce: protezione o rischio?},
  journal = {Medico e Bambino},
  year = {2026},
  volume = {45},
  number = {4},
  pages = {225--230},
  doi = {10.53126/meb45225}
}
Kostenlos starten →